Steve E. Krognes - 18 Jun 2021 Form 4 Insider Report for Gritstone bio, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 18 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Nov 2021, 16:25:47 UTC
Next SEC filing: 23 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Rahsaan Thompson, Attorney-in-Fact for Steve E. Krognes

Key filing fact

Steve E. Krognes filed Form 4 for Gritstone bio, Inc. on 19 Nov 2021.

Key facts

This page summarizes Steve E. Krognes's Form 4 filing for Gritstone bio, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Nov 2021, 16:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRTS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +19,000
Change %
Price: $0.000000
Shares after: 19,000
Date: 18 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,000
Exercise price: $9.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest and become exercisable on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.